Professional Documents
Culture Documents
Assessment
Page 1 of 78
REGISTRATION REPORT
CORE ASSESSMENT
Applicant: F. Khalili
Date: July 2015
Table of Contents
IIIA 10 ECOTOXICOLOGICAL STUDIES ................................................................... 5
IIIA 10.1 Effects on Birds...................................................................................................... 7
IIA 10.1.1 Acute toxicity exposure ratio (TERA).................................................................. 9
IIIA 10.1.2 Short and long-term toxicity exposure ratio (TERST) .................................... 11
IIIA 10.1.3 Baits: Concentration of active substance in bait in mg/kg ............................. 13
IIIA 10.1.4 Pellets, granules, prills or treated seed .............................................................. 13
IIIA 10.1.4.1 Amount of active substance in or on each item ................................................ 13
IIIA 10.1.4.2 Proportion of active substance LD50 per 100 items and per gram of
items...................................................................................................................... 13
IIIA 10.1.5 Size and shape of pellet, granule or prill........................................................... 14
IIIA 10.1.6 Acute toxicity of the formulation ....................................................................... 14
IIIA 10.1.7 Supervised cage or field trials ............................................................................ 14
IIIA 10.1.8 Acceptance of bait, granules or treated seeds (palatability testing) ............... 14
IIIA 10.1.9 Effects of secondary poisoning ........................................................................... 14
IIIA 10.2 Effects on Aquatic Organisms............................................................................ 15
IIIA 10.2.1 Toxicity exposure ratios...................................................................................... 19
IIIA 10.2.1.1 TERA for fish ....................................................................................................... 19
IIIA 10.2.1.2 TERLT for fish...................................................................................................... 19
IIIA 10.2.1.3 TERA for Daphnia ............................................................................................... 20
IIIA 10.2.1.4 TERLT for Daphnia ............................................................................................. 21
IIIA 10.2.1.5 TERA for aquatic insect ...................................................................................... 21
IIIA 10.2.1.6 TERLT for aquatic insect..................................................................................... 21
IIIA 10.2.1.7 TERA for aquatic crustacean.............................................................................. 22
IIIA 10.2.1.8 TERLT for aquatic crustacean ............................................................................ 22
IIIA 10.2.1.9 TERA for aquatic gastropod mollusc................................................................. 22
IIIA 10.2.1.10 TERLT for aquatic gastropod mollusc ............................................................... 23
IIIA 10.2.1.11 TERLT for algae ................................................................................................... 23
IIIA 10.2.1.12 TER for aquatic plants ....................................................................................... 24
IIIA 10.2.2 Acute toxicity of the formulation ....................................................................... 25
IIIA 10.2.2.1 Fish........................................................................................................................ 26
IIIA 10.2.2.2 Aquatic invertebrates (Daphnia) ....................................................................... 26
IIIA 10.2.2.3 Algae ..................................................................................................................... 26
IIIA 10.2.2.4 Marine or estuarine organisms .......................................................................... 29
IIIA 10.2.2.5 Marine sediment invertebrates .......................................................................... 29
IIIA 10.2.3 Microcosm or mesocosm study .......................................................................... 29
IIIA 10.2.4 Residue data in fish ............................................................................................. 29
IIIA 10.2.5 Chronic toxicity to fish........................................................................................ 29
IIIA 10.2.5.1 28 day study ......................................................................................................... 29
IIIA 10.2.5.2 Fish early life stage test ....................................................................................... 30
IIIA 10.2.5.3 Fish life cycle test................................................................................................. 30
IIIA 10.2.6 Chronic toxicity to aquatic invertebrates.......................................................... 30
IIIA 10.2.6.1 21 day test (Daphnia magna).............................................................................. 30
IIIA 10.2.6.2 Aquatic insect....................................................................................................... 30
IIIA 10.2.6.3 Aquatic gastropod mollusc ................................................................................. 30
IIIA 10.2.7 Accumulation in aquatic non-target organisms ............................................... 30
IIIA 10.3.1 Toxicity exposure ratios...................................................................................... 32
Where appropriate this document refers to the conclusions of the EU review of the Gibberellic acid. This
will be where:
x the active substance data is relied upon in the risk assessment of the formulation; or when
x the EU review concluded that additional data/information should be considered at national re-
registration.
Note: this Part B document only reviews data (Annex II or Annex III) and additional information that has
not previously been considered within the EU review process, as part of the Annex I inclusion decision.
New annex II data must only be included if they are considered essential for the evaluation and in this
case a full study summary must be provided. In the case where the formulation has been previously
evaluated, at European level, detailed summaries have not been provided.
This product was not the representative formulation. The product has not been previously evaluated
according to Uniform Principles.
The SANCO report (SANCO/2613/08– rev. 2, 1 June 2012) and the EFSA conclusions (EFSA Journal
2012;10(1):2507) for Gibberellic acid are considered to provide the relevant review information or a
reference to where such information can be found. Each section will begin with a table providing the EU
endpoints to be used in this evaluation.
The Annex of the Regulation (EC) No 1107/2009 (Regulation No 540/2011 of 25 May 2011) provides
specific provisions under Part B which need to be considered by the applicant in the preparation of their
submission and by the MS prior to granting an authorisation.
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on the
Gibberellic acid (SANCO/2613/08) and in particular Appendices I and II thereof, as finalised in the
Standing Committee on the Food Chain and Animal Health shall be taken into account.
Appendix 1 of this document contains the list of references included in this document for support of the
evaluation.
Appendix 2 of this document is the table of intended uses for GIBER GOBBI 10
Appendix 3 of this document contains any additional information provided by the applicant.
Information on the detailed composition of GIBER GOBBI 10 can be found in the confidential dossier of
this submission (Registration Report - Part C).
Introduction
This section of the submission summarises the ecotoxicological effects of the formulation and evaluates
the potential risk to various representatives of terrestrial, aquatic and soil organisms. Full details or the
proposed use pattern that will be assessed are shown in Appendix 2 of this document and summarised in
Table 10-1.
Consideration of metabolites
The occurrence and risk from potentially ecotoxicologically relevant metabolites have been considered,
detailed discussion was provided in the EU review (Gibberellic acid) and in Part B, Section 5.
Considering that Gibberellic acid is naturally occurring, any formed metabolites are also naturally
occurring. Therefore, it was concluded that there is no relevant metabolite.
Effects on birds for GIBER GOBBI 10 were not evaluated as part of the EU review of Gibberellic acid.
However further data on GIBER GOBBI 10 is not relevant as active substance data on toxicity to birds is
used and additional formulation data are not considered essential. Therefore all relevant data were
assessed in the EU review. Risk assessments for GIBER GOBBI 10 with the proposed use pattern are
provided here and are considered adequate.
The risk assessments were conducted in accordance with the Guidance of EFSA: Risk Assessment for
Birds and Mammals (2009)1.
Risk Assessment
Toxicity
Birds are typically exposed to dry residues on their food items following the dilution and spraying of the
formulated product. During these processes, much of the formulation constituents are likely to be lost by
volatilisation. Since oral exposure is the main route of exposure, toxicity data for the active substances are
therefore used in preference to data from tests with the formulated material. On this basis, the risk to birds
from the proposed uses of GIBER GOBBI 10 will be assessed using data on Gibberellic acid.
Avian acute oral and short-term dietary have been carried out with Gibberellic acid. Full details of
Gibberellic acid avian toxicity studies are provided in EU DAR. No studies have been performed to
determine the sub-chronic and reproductive toxicity of Gibberellic acid (GA3) to birds.
However, Gibberellic acid is ubiquitous in the tissues of plants and therefore represents a habitual
component of the diet of herbivorous birds and insectivorous birds that feed upon herbivorous arthropod
prey. Moreover, Gibberellic acid is a plant hormone and as such requires application at only low rates to
elicit the desired response in the target plants. Based on the weight of evidence provided by acute and
short-term dietary toxicity studies summarised below (table 10.1-2), subchronic and reproductive avian
toxicity endpoints for Gibberellic acid (GA3) are not expected to be sufficiently low for any meaningful
risks to arise at the rates applied in the field. Consequently, studies to determine the subchronic and
reproductive avian toxicity of Gibberellic acid (GA3) and the concomitant expenditure of vertebrate test
animals are not justified.
1
Guidance of EFSA: Risk Assessment for Birds and Mammals. European Food Safety Authority (EFSA), Parma, Italy, EFSA
Journal 2009; 7(12):1438
Further data on subchronic toxicity and reproductive toxicity to birds is therefore not considered
necessary.
A summary of the relevant acute and short-term endpoints is provided in Table 10.1-2.
Exposure
Exposure of birds will be predominantly dietary, through the consumption of residues on food items.
Direct exposure of birds to GIBER GOBBI 10 applications is considered unlikely, since at the time of
application and for a short period thereafter, most birds will leave the immediate vicinity of spray
operations in response to the human disturbance.
The SV is a default value for the species of concern (i.e. the indicator species, the generic focal species or
the focal species), derived according to formula:
Indicator species relevant for the intended uses and SV values are presented in the Table 10.1.1-1.
Table 10.1.1-1. Acute shortcut values (based on 90th percentile residues) for avian indicator species
Shortcut value
Crop Corresponding crop group Indicator species for acute
assessment
Pear, cherry and Small insectivorous
Orchards and ornamentals/nursery 46.8
citrus bird
Small omnivorous
Grape Vineyard 95.3
bird
Bulbs and onion like crops, cereals, fruiting
vegetables, leafy vegetables, legume
Tomato, eggplant Small omnivorous
forage, maize, oilseed rape, potatoes, pulses, 158.8
and artichokes bird
root and stem vegetables, strawberries, sugar
beet, and sunflower
For multiple applications, the DDD for single application is multiply by an appropriate multiple
application factor for 90th percentile reside data (MAF):
As recommended, the risk envelope approach was used for the risk assessment for birds according to the
guidance document SANCO/11244/2011 rev. 5.
2
Guidance of EFSA: Risk Assessment for Birds and Mammals. European Food Safety Authority (EFSA), Parma, Italy, EFSA
Journal 2009; 7(12):1438
Applicant Document ID - 4522***_F dRR GIBBER GOBBI 10 Evalud: Date : 12 /18
Applicant Author: F. Khalili
Part A – Core Registration Report
Assessment
Page 10 of 78
Table 10.1.1-2: Summary of crop grouping for the risk envelope approach
Maximum
Maximum number Interval
Crop group Crops included application rate MAF
of applications (days)
[g as/ha]
Pear 12 1 - -
Orange, lemon,
20 1 - -
Orchards cherry
Clementine,
10 2 7 1.4
mandarin
Vineyard Grapes 30 2 5 1.5
Fruiting Tomato, eggplant 10 3 7 1.6
vegetables and
leafy vegetables Artichoke 20 3 15 1.3
In bold, worst case scenario considered for risk assessment
Screening Step
The acute risk assessment for the use of GIBER GOBBI 10 is presented in Table 10.1.1-3.
The TERA values are greater than the Annex VI trigger of 10, indicating low acute risk to birds from
Gibberellic acid following application of GIBER GOBBI 10 at all proposed label rates.
3
Guidance of EFSA: Risk Assessment for Birds and Mammals. European Food Safety Authority (EFSA), Parma, Italy, EFSA
Journal 2009; 7(12):1438
Applicant Document ID - 4522***_F dRR GIBBER GOBBI 10 Evalud: Date : 12 /18
Applicant Author: F. Khalili